Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Clinical Liver Disease|July 28, 2022
Portal pressure reductions induced by nonselective beta-blockers improve outcomes and decrease mortality in patients with cirrhosis with and without ascitesLaura Turco, Guadalupe García-TsaoNature Reviews. Disease Primers|June 10, 2016
Acute-on-chronic liver failure in cirrhosisVicente Arroyo, Richard Moreau, Patrick S Kamath, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 9, 2019
Lowering Portal Pressure Improves Outcomes of Patients With Cirrhosis, With or Without Ascites: A Meta-AnalysisLaura Turco, Candid Villanueva, Vincenzo La Mura, et al.Alimentary Pharmacology & Therapeutics|February 19, 2025
Comparison Between Dynamic Models for Predicting Response to Corticosteroids in Alcohol-Associated Hepatitis: A Global Cohort StudyFrancisco Idalsoaga, Luis Antonio Díaz, Leonardo Guizzetti, et al.Hepatology Communications|March 25, 2025
Moderate alcohol-associated hepatitis: A real-world multicenter studyFrancisco Idalsoaga, Luis Antonio Díaz, Winston Dunn, et al.JHEP Reports : Innovation in Hepatology|July 17, 2023
MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitisLuis Antonio Díaz, Eduardo Fuentes-López, Gustavo Ayares, et al.Hepatology (Baltimore, Md.)|April 12, 2024
An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort studyWinston Dunn, Yanming Li, Ashwani K Singal, et al.Journal of Hepatology|June 24, 2021
Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide studyJuan Pablo Arab, Luis Antonio Díaz, Natalia Baeza, et al.Pageof 1